U.S. Stock News

NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

RadNet (RDNT) Q4 Loss On US$547.7m Revenue Tests Margin Expansion Narrative

RadNet (RDNT) closed out FY 2025 with Q4 revenue of US$547.7 million and basic EPS of roughly US$0.01 loss, while trailing twelve month figures show revenue at about US$2.0 billion and basic EPS of roughly US$0.25 loss. The company has seen quarterly revenue move from US$471.4 million in Q1 2025 to US$547.7 million in Q4 2025, with basic EPS swinging between a US$0.51 loss and US$0.19 profit over the same span. This sets up a story that focuses on how quickly margins can stabilize from...
NasdaqGS:LIN
NasdaqGS:LINChemicals

A Look At Linde (LIN) Valuation As Rising Natural Gas Costs Pressure Margins

Linde (LIN) is back in focus as the stock reacts to rising natural gas costs tied to Middle East tensions and the closure of the Strait of Hormuz, a key route for global energy supplies. See our latest analysis for Linde. Beyond the immediate reaction to energy cost concerns, Linde’s share price has shown strong momentum, with an 11.46% 30 day share price return and an 18.70% year to date share price return. Over a longer horizon, the 1 year total shareholder return of 11.67% and 5 year total...
NYSE:DQ
NYSE:DQSemiconductor

Improving 2025 Losses And Higher 2026 Output Guidance Might Change The Case For Investing In Daqo New Energy (DQ)

Daqo New Energy Corp. recently reported its fourth-quarter and full-year 2025 results, showing polysilicon production of 42,181 MT in the quarter and 123,652 MT for the year, alongside full-year sales of US$665.42 million and a net loss of US$170.51 million, and issued 2026 production guidance of 140,000–170,000 MT. The sharp year-on-year reduction in net loss and the company’s plan to lift output in 2026 suggest operations are gradually stabilizing despite ongoing industry overcapacity...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Assessing Ulta Beauty (ULTA) Valuation After Bullish Analyst Updates And International Expansion

Ulta Beauty (ULTA) is back in focus after recent analyst updates highlighted strong holiday sales, expanding store space, and new partnerships, along with rapid international growth and leadership changes that are drawing fresh investor attention. See our latest analysis for Ulta Beauty. Ulta Beauty’s share price has climbed steadily over recent months, with a 23.5% 90 day share price return and a 94.1% 1 year total shareholder return, suggesting momentum has built as investors react to...
NYSE:EOG
NYSE:EOGOil and Gas

A Look At EOG Resources (EOG) Valuation After Recent Share Price Strength

EOG Resources (EOG) has drawn fresh attention after its recent share move, with the stock last closing at $128.65. That puts its recent performance and underlying fundamentals back in focus for investors. See our latest analysis for EOG Resources. The recent 1 day share price return of 3.68% extends a stronger run, with a 30 day share price return of 14.73% and a 5 year total shareholder return of 120.24%. This suggests momentum has been building over both shorter and longer periods. If this...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

The Bull Case For Alnylam Pharmaceuticals (ALNY) Could Change Following AMVUTTRA Uptake And Canada Reimbursement News

In late February 2026, Alnylam Pharmaceuticals highlighted strong momentum for its RNAi franchise, including positive Phase 3 data and a favorable Canadian reimbursement recommendation for AMVUTTRA in transthyretin-mediated amyloid cardiomyopathy, alongside an upcoming presentation at the TD Cowen Health Care Conference in Boston. Together with upbeat analyst commentary on AMVUTTRA’s rollout and Alnylam’s growth profile, these updates have sharpened investor focus on the company’s rare...
NYSE:PSX
NYSE:PSXOil and Gas

Phillips 66 Weighs Venezuelan Crude Deal As Valuation Signals Upside Potential

Phillips 66, ticker NYSE:PSX, is seeking approval to purchase Venezuelan heavy crude directly from state owned producer PDVSA. The proposed move would allow the refiner to source crude without intermediaries, potentially reshaping its supply chain and cost structure. This development comes as US refiners assess supply options in light of shifting geopolitical and regulatory conditions around Venezuelan oil. For investors watching NYSE:PSX, this sourcing shift sits alongside a share price of...
NasdaqCM:CELH
NasdaqCM:CELHBeverage

Assessing Celsius Holdings (CELH) Valuation After Earnings Surge And Subsequent Profit Taking Pullback

Celsius Holdings (CELH) just reported fourth quarter and full year 2025 results, showing strong revenue growth and a swing to quarterly profitability. The report was followed by a sharp share price pullback as investors locked in gains. See our latest analysis for Celsius Holdings. That profit taking drop of 8.13% on the 1 day share price return comes after a strong run, with a 90 day share price return of 20.62% and a 1 year total shareholder return of 92.01%. Momentum has cooled slightly,...
NYSE:QGEN
NYSE:QGENLife Sciences

Is Qiagen (NYSE:QGEN) Attractive After Recent 9% Pullback And DCF Upside Estimate

Wondering whether Qiagen is still good value at around US$48.83, or if the easy gains are behind it? This article walks through the numbers so you can judge the price tag with more confidence. The stock is up 28.2% over the past year and 2.7% year to date. However, the past 30 days have seen a 9.0% decline after a 2.9% gain in the last week, which may have shifted how the market is thinking about risk and opportunity. Recent news around Qiagen has focused on its position in pharmaceuticals...
NYSE:BK
NYSE:BKCapital Markets

A Look At Bank of New York Mellon Corporation’s Valuation As Blockchain And AI Initiatives Draw Market Attention

Why BNY’s new preferred stock moves matter for common shareholders Bank of New York Mellon Corporation (BK) has launched a proposed public offering of Series M Noncumulative Perpetual Preferred Stock via depositary shares, alongside a completed US$500m variable rate preferred fixed income deal. For you as a common shareholder, these preferred moves sit alongside BNY’s push into blockchain settlement, tokenization and AI driven onboarding. Together, they raise questions about capital...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

Trupanion’s Return To Profitability And Pricing Shift Might Change The Case For Investing In TRUP

In late February 2026, Trupanion reported its full-year 2025 results, highlighting a return to profitability with net income of US$19.4 million and surpassing US$1.00 billion in annual subscription revenue driven by pricing aligned to rising veterinary costs and improved operating margins. The company also issued an optimistic 2026 outlook, projecting total revenue of about US$1.55–US$1.58 billion and targeting adjusted operating income growth of roughly 19%, while exploring lower-priced...
NYSE:XOM
NYSE:XOMOil and Gas

Did Middle East Tensions and a Board Change Just Shift Exxon Mobil's (XOM) Investment Narrative?

In recent days, escalating conflict involving Iran and effective disruption around the Strait of Hormuz have pushed global oil prices sharply higher, focusing attention on Exxon Mobil’s large upstream operations. At the same time, Exxon Mobil confirmed that director Jeffrey W. Ubben will not seek re-election at the May 2026 shareholder meeting, though his departure is described as unrelated to the company. These developments highlight how sudden geopolitical supply risks can reinforce the...
NYSE:SR
NYSE:SRGas Utilities

A Look At Spire (SR) Valuation After Preferred Stock Termination And Recent Earnings And Dividend Updates

Spire (SR) has drawn fresh attention after terminating the certificate of designations for its 5.90% Series A Cumulative Redeemable Perpetual Preferred Stock, along with recent earnings and dividend updates in the natural gas utilities sector. See our latest analysis for Spire. That change to Spire’s capital structure comes as the share price trades at US$91.66, with a 30 day share price return of 8.49% and a 1 year total shareholder return of 22.45%. The 5 year total shareholder return of...
NYSE:PFE
NYSE:PFEPharmaceuticals

Does New Oncology Data Shift The Pipeline-Driven Bull Case For Pfizer (PFE)?

In late February 2026, Pfizer and Astellas reported that PADCEV plus Keytruda cut the risk of tumor recurrence, progression or death in cisplatin-eligible muscle-invasive bladder cancer patients versus standard chemotherapy, while Pfizer also secured full FDA approval for BRAFTOVI-based combination therapy in first-line BRAF V600E-mutant metastatic colorectal cancer. Together, these oncology advances strengthen Pfizer’s presence in high-need cancer settings and may help offset pressure from...
NYSE:RRC
NYSE:RRCOil and Gas

Assessing Range Resources (RRC) Valuation After Record 2025 Results And Higher Dividend

Range Resources (RRC) is back in focus after reporting 2025 results with record operational efficiencies, setting a new 2026 capital plan and production guidance, and lifting its quarterly dividend payout to shareholders. See our latest analysis for Range Resources. The recent earnings beat, operational records and dividend increase appear to be feeding into solid momentum, with a 7 day share price return of 8.6% and a year to date share price return of 18.6%, while the 5 year total...
NYSE:BIO
NYSE:BIOLife Sciences

Assessing Bio-Rad (BIO) Valuation After Mixed Share Price Performance And Recurring Revenue Shift

Bio-Rad Laboratories (BIO) has been drawing attention after a mixed stretch for the share price, with gains over the past year but declines over the past 3 months and year to date. See our latest analysis for Bio-Rad Laboratories. Recent trading has been choppy, with a 4.23% 7 day share price return following a weaker 30 day share price return of a 4.80% decline. A 12.23% decline over 90 days points to fading momentum despite a 9.02% 1 year total shareholder return. If this mixed performance...
NYSE:MMS
NYSE:MMSProfessional Services

Assessing Maximus (MMS) Valuation After Recent Share Price Weakness

Event context and recent share performance Maximus (MMS) has come onto investors’ radar after a period of mixed share performance. The stock is down roughly 22% over the past month and about 15% over the past 3 months. See our latest analysis for Maximus. Against this recent slide, Maximus still has a 1 year total shareholder return of 16.64%. However, the 3 year and 5 year total shareholder returns of 6.02% and 6.59% declines suggest fading longer term momentum. If Maximus’ move has you...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Assessing Webull (BULL) Valuation After Recent Share Price Swings And Mixed Growth Expectations

Why Webull’s Recent Performance Has Caught Investor Attention Webull (BULL) has been on many watchlists after a mixed stretch in its share performance, with a 4% gain over the past day and 7.9% over the past week, offset by weaker month and past 3 months returns. At a last close of US$6.04, the digital trading platform shows annual revenue of about US$514.8m alongside a net loss of roughly US$524.7m, which puts profitability front and center for many investors assessing the stock. See our...
NYSE:CAG
NYSE:CAGFood

Conagra Board Refresh Brings Retail And Foodservice Focus To Undervalued Stock

Conagra Brands (NYSE:CAG) has added John Mulligan and Pietro Satriano to its board of directors. Mulligan and Satriano bring leadership experience from Target, McDonald's, US Foods, and Loblaw. The appointments signal a focus on retail operations, finance, and foodservice expertise at the board level. Conagra Brands, trading at $19.18, sits in a challenging spot after a 20.8% decline over the past year and a 33.5% decline over five years, even with a 10.9% gain year to date. For investors...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Valuation Check As SoFiUSD Stablecoin Settlement Deal Reshapes Its Payments Future

Why the SoFiUSD partnership matters for Mastercard stock Mastercard (MA) is putting stablecoins directly into its core plumbing, partnering with SoFi to let SoFiUSD settle card transactions across its global network and plug into its Multi Token Network. For you as a shareholder or prospective investor, this move brings stablecoin adoption, blockchain based settlement and card network economics into the same conversation. It raises fresh questions about how Mastercard’s business model could...
NYSE:CSR
NYSE:CSRResidential REITs

The Bull Case For Centerspace (CSR) Could Change Following 2026 Loss Guidance After 2025 Profitability

In February 2026, Centerspace reported fourth-quarter 2025 results showing sales of US$66.62 million and a net loss of US$18.38 million, alongside full-year sales of US$273.66 million and net income of US$17.59 million. The company paired this with 2026 guidance calling for a diluted net loss per share of US$0.49 to US$0.19, signaling a potential step back after returning to profitability in 2025. Next, we’ll examine how Centerspace’s return to profit in 2025 but projected loss in 2026...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Assessing Microsoft (MSFT) Valuation After Strong Q2 AI And Cloud Momentum

Microsoft (MSFT) is back in focus after its fiscal second quarter highlighted strong cloud and AI demand, with commercial bookings and Microsoft Cloud revenue both growing, and new Copilot deployments rolling out across large enterprise and healthcare clients. See our latest analysis for Microsoft. Even with strong AI and cloud headlines, Microsoft’s recent share price tells a different story. The 30 day share price return is 7.4% and the 90 day share price return is 18.7%, while the 1 year...
NYSE:IRM
NYSE:IRMSpecialized REITs

Will Falling Short Interest Signal a Deeper Shift in Iron Mountain's (IRM) Investor Confidence?

In recent weeks, Iron Mountain Inc. has seen its short interest fall by 14.69%, with 3.6% of its freely traded shares now sold short, below the peer average of 5.54%. This pullback in bearish positioning suggests a meaningful shift in sentiment, as investors appear relatively more confident in Iron Mountain’s outlook than in many of its peers. With this backdrop of easing short interest, we’ll explore how changing investor sentiment could influence Iron Mountain’s evolving investment...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

Is AXT (AXTI) Using AI-Focused Indium Phosphide To Reframe Persistent Losses Into Strategy?

AXT, Inc. has reported its fourth-quarter 2025 results, with sales of US$23.04 million and a net loss of US$3.55 million, while full-year 2025 sales reached US$88.33 million alongside a net loss of US$21.26 million. The company’s quarterly loss narrowed compared with a year earlier even as full-year losses increased, setting an interesting backdrop for its push into indium phosphide substrates for AI-related infrastructure. We’ll now examine how AXT’s efforts to expand indium phosphide...